The normal degree of intra-and inter-individual variation in gene transcription profiles of healthy human tissues has not been extensively investigated. In the study described here, microarrays were employed to analyse gene transcription in peripheral blood mononuclear cells prepared from serial blood samples that had been obtained, at weekly intervals, from apparently healthy human volunteers. Transcript levels for the majority of genes examined were found to be remarkably consistent within samples from a single donor. Conversely, marked differences were observed in samples obtained from different donors. Genes that exhibited differential expression dependent on sex, age, body mass index and the presence of varying proportions of different leucocyte subsets were identified. These results emphasise the important contributions of genetic and environmental factors, as well as varying representation of different cell types, in determining the overall gene transcriptional profiles of human tissues. However, the study also provides evidence that, within an individual, the gene transcription profiles of sampled tissues can be comparatively stable over time.
INTRODUCTION
Microarrays have proved to be highly effective tools for mapping gene transcriptional profiles in cells and tissues. They have been used most extensively and to greatest effect in comparative studies; identifying genes that are differentially expressed in response to developmental changes, specific environmental exposures and disease (1, 2, 4, 5, 9, 15) . In contrast, few microarray studies have focused upon "healthy" patterns of gene expression in non-diseased individuals, and still fewer have sought to describe the normal extent of inter-and intra-individual variation in apparently healthy human volunteers (10, 16) .
Such information is essential to provide a basis for a comprehensive understanding of normal tissue functions and the impact of genetic and environmental factors on these. These data are also needed for the development of more robust designs for clinical and nutritional intervention studies involving complex gene expression analysis.
In the study described here, microarrays were used to analyse gene transcription profiles in peripheral blood mononuclear cells (PBMC) isolated from 18 (10 female and 8 male) apparently healthy human volunteers. Each volunteer provided a series of five blood samples taken first thing in the morning, after an overnight fast, at weekly intervals with each sample being taken sequentially on a different day of the normal working week.
PBMC from venous blood samples were selected for analysis because blood is an accessible tissue that is used in many clinical and nutritional studies. Peripheral blood leucocytes are often used as surrogates for predicting potential effects in inaccessible tissues. Their validity in this respect is likely to be highly dependent on the context of the research and thorough evaluation is still required to further validate their use. Definition of the normal degree of variation, as well as the responsiveness of gene expression in these cells to environmental factors, will provide a key component in this process.
Whole blood is an example of a complex tissue that contains a number of different cell types. Each of these cell types expresses a unique pattern of gene transcription relating to its specific function. Whitney and co-workers have demonstrated clear correlation between the expression of specific groups of genes in whole blood RNA isolates and the representation of cell types (erythrocytes and leucocyte subsets) in said samples (16) . In the current study, this source of variation was reduced by using PBMC instead of whole blood. PBMC were isolated immediately after collection of blood using a protocol designed to minimise sample processing time and maximise the consistency of processing between samples. The content of different leucocyte subsets in the PBMC preparations was determined by flow cytometric analysis. Total RNA from each PBMC sample was analysed in duplicate on oligonucleotide-based arrays produced in-house (each containing features representing 13,927 genes). Of the genes represented on these arrays, reliable signal (in at least 95% of the samples) was obtained for 8,489 genes. The transcript profiles of these genes were examined for apparent effects of sex, age, body mass index (BMI) and the presence of varying proportions of different leucocyte subsets within the PBMC preparations. The variation in transcription levels for most genes across sample sets from individuals was comparatively small, with average withinsubject coefficients of variation less than 20% for 80% of the genes examined. However, a high proportion of genes (39% or 58% depending on the method of analysis) exhibited significant inter-individual differences in transcript levels. As might be expected, it proved possible to distinguish perfectly between samples from each donor by applying unsupervised hierarchical clustering, using subsets of these genes (431 down to 137) defined by statistical comparisons of increasing stringency between volunteers. The genes present in these sets were observed to cover a wide range of biological functions (determined from on gene ontology annotation) including notable clusters of genes involved in immune function, interferon-regulated genes, histones and X or Y-linked genes.
These data extend the currently very limited information base that specifically describes the degree of normal variation in the expression of genes in healthy human tissues. The results suggest that genetic and environmental factors elicit substantial inter-individual differences in the expression of many genes, but also that the overall expression profile in PBMC is comparatively stable within an individual over time.
MATERIALS AND METHODS

Materials
RNase inhibitor and ultra-pure dNTPs were purchased from Promega (Southampton, UK). Superscript II RNase H -Reverse Transcriptase was purchased from Invitrogen Ltd (Paisley, UK). 5-(3-Aminoallyl)-2'-deoxyuridine 5'-triphosphate sodium salt was purchased from Sigma-Aldrich (Poole, UK). Cy Dye post-labelling reactive dye packs were from Amersham Biosciences (Little Chalfont, UK). MicroCon-30 centrifugal ultra-filtration units were from Millipore Ltd (Watford, UK). RNeasy RNA isolation kits and QIAquick PCR purification kits were purchased from Qiagen Ltd (Crawley, UK). Epoxycoated Schott Nexterion (Stafford, UK) slides (slide E) were used for the microarrays. Anti-CD3-pe and CD19-fitc antibodies were produced in-house. All others (anti-CD14-ecd, anti-CD16-CyChr and anti-CD56-CyChr) were purchased from BD Biosciences (Cowley, UK). BD Vacutainer™ CPT™ tubes were purchase from BDMedical (Cowley, UK). Universal Human Reference RNA was purchased from Stratagene (Amsterdam, Netherlands).
Volunteers and blood samples
Approval for the study was obtained from both the Institute of Food Research Human Research Governance Committee and the Norwich Local Research Ethics Committee. Male and female volunteers (aged between 20 and 45 years) were recruited and included on the study if they satisfied the following inclusion criteria: non-smokers (and had not smoked for at least 6 months prior to the study); were not taking regular prescribed medication (including hormone replacement therapy and oral contraception); were not pregnant nor had been pregnant during the 12 months prior to the study; had not received inoculations within four months of starting the study or planned during the study; had not donated or intended to donate blood within 16 weeks of the first and last study samples; were not diagnosed with any long-term medical condition (e.g. diabetes, haemophilia, cardiovascular disease, glaucoma, anaemia, gastrointestinal disease); were not experiencing symptoms of allergy (individuals with allergy controlled by avoidance were accepted provided they were not currently experiencing symptoms). Written informed consent was obtained from each volunteer prior to commencing the study.
On their first visit, the volunteers' heights and weights were measured, their blood pressures and pulses monitored, and urine and fasting venous blood samples taken for the purpose of general health screening. Volunteers were excluded from further participation in the study according to the following criteria: BMI was below 17 or above 31 kg/m 2 ; blood pressure was lower than 100/50 or higher than 140/90 mmHg; pulse exceeded 90 beats per minute; analysis of urine revealed pH, protein, glucose, ketones, urobilinogen, bilirubin, leucocytes, nitrites, or blood/haemoglobin levels outside normal ranges; fasting blood glucose, haemoglobin, full blood cell count, or urea and electrolytes concentrations fell outside normal range and were considered, upon review by a consultant physician, to be sufficient cause for exclusion.
Volunteers who met these criteria commenced a series of five visits at one week intervals to the Institute's human nutrition unit to provide overnightfasted venous blood samples. The visits were timed such that each of the samples from one volunteer was collected on sequential mornings of the week (Monday to Friday). Ten female and eight male volunteers completed the study. All five samples were collected from 16 of the volunteers and one sample was missed out by each of the two remaining volunteers (both male). On each visit the volunteers were asked if they had been unwell during the previous week and any illness that they reported or over-the-counter medication they had taken was recorded. All samples were anonymised.
Sample processing
Blood samples (60 ml) were drawn from an antecubital vein in each volunteer's forearm. Each subsequent step involved in the processing for the isolation of PBMC RNA was performed without delay following collection of the blood. The majority of each sample (56 ml) was transferred to a set of seven BD Vacutainer® CPT™ tubes (8ml draw volume each), containing sodium citrate as anti-coagulant, for isolation of PBMC according to the manufacturer's instructions and as detailed below. The remaining portion (4 ml) of each blood sample was transferred into an EDTA anticoagulant tube for isolation and storage (at -80 °C) of plasma following centrifugation at 2000 x g for 20 minutes at 20 °C.
After centrifugation for 20 minutes at 1500 x g, 20 °C, the unopened BD Vacutainer® CPT™ tubes were inverted gently five times to mix the plasma plus mononuclear cell layer present above the polyester gel. The entire content of each tube above the gel layer was decanted into fresh tubes with all the preparations originating from a single blood sample being pooled at this time. Two portions of the cell suspension (5 ml and 0.7 ml) were removed for PBMC protein extraction and for flow cytometric analysis (described below). The remaining cell suspension was diluted with one volume of physiological saline and then centrifuged at 300 x g, 20 °C for 15 minutes. The liquid was decanted and total RNA extracted from the cell pellet using RNeasy midi kits according to the manufacturer's instructions.
Flow Cytometric Analysis of PBMC preparations
The 0.7 ml portion of cell suspension from each sample was collected and washed twice with 1ml saline (0.9% w/v) containing 0.15% w/v EDTA (SE buffer). Cells were recovered after each wash by centrifugation at 300 x g. Cell pellets were resuspended in 0.5 ml SE buffer and aliquots removed for immunofluorescent antibody staining.
Fluorescently-labelled antibodies against CD3, CD14 and CD19 were used to detect T-cells, B-cells and monocytes, respectively, and a combination of antibodies against CD16 and CD56 was used detect natural killer cells. Antibody titrations were performed to determine optimal dilutions for each antibody used. Equal volumes (50 µl of each) of freshly prepared antibody cocktail and cell suspension (2x10 6 cells/ml) were mixed together and incubated for 15 minutes at room temperature in the dark. Stained cells were washed twice with phosphate buffered saline containing 1% w/v bovine serum albumin, 1% w/v sodium azide and 0.15% w/v EDTA. Resuspended cells were fixed with 1% w/v (final concentration) paraformaldehyde and subsequently stored for up to 7 days at 4°C until flow cytometric analysis and data acquisition. Fluorescence data were acquired on a 6-parameter Beckman Coulter Altra flow cytometer equipped with 488 nm argon ion and 635 nm HeNe lasers and analysed using Expo32 software (Beckman Coulter (UK) Limited, High Wycombe, UK).
Microarray production and analysis
Microarrays were produced using a commercial set of 14,001 (70-72mers) oligonucleotides (Operon human oligonucleotide set version 1.0, Operon Biotechnologies GmbH Technologies, Cologne, Germany), which consisted of 13,971 gene specific oligonucleotides, 29 negative controls and one positive control (an equimolar mixture of the 13,971 gene-specific oligonucleotides). A set of additional controls was added to the set including 6 yeast gene-specific oligonucleotides, and Cy3-and Cy5-labelled PCR products for an E. coli gene (FixC) that were used as "landing lights" to confirm the correct printing order and orientation of oligonucleotides on the arrays. The oligonucleotides were printed onto epoxy-coated slides using a Stanford design arraying robot (14) . Prior to hybridization the printed arrays were post-processed according to the slide manufacturer's instructions.
The yield, purity and integrity of each RNA sample was determined by spectrophotometric analysis at 260 and 280 nm and by using an Agilent 2100 bioanalyser with RNA 6000 Nano chips (Agilent Technologies UK Limited, South Queensferry, UK) and RNA 6000 ladder (Ambion Europe Limited, Huntingdon, UK). The A260 nm/A280 nm ratio for all samples was between 1.8 and 2.2. The 28S/18S rRNA ratios were all between 1.5 and 2.1. The average RNA yield was 97 ± 34 µg (range 41 to 175 µg).
Cy5-labelled cDNA was produced by reverse transcription of test RNA samples (20 µg each) using an established indirect labelling protocol with minor modifications (6) . Cy3-labelled reference cDNA was produced from the Universal Human Reference RNA, prepared according to the manufacturer's instructions, in the same manner as the PBMC samples.
Each test sample, together with a reference sample, was hybridized to two arrays on separate occasions. Initially, ten batches of hybridizations (each consisting of 16-18 arrays) were set up. To avoid any potential for introducing experimental bias, the samples were randomly allocated to the different batches. The randomisation was performed with two restraints; each batch contained no more than one sample originating from any given volunteer and either three or four samples numbered 1 to 5 (where sample 1 was the first sample obtained from a volunteer and sample 5 the last). An 11 th batch of arrays was set up to accommodate repeat analyses of samples for which uneven hybridization or background signal meant that a large number of features had to be rejected during image analysis of one of the first two technical replicates. In all, 184 arrays were included in the final analysis, representing duplicate arrays for 70, triplicate arrays for 13, and single arrays for 5 samples.
Hybridizations were performed overnight at 70 °C according to an established protocol (7) . Following hybridization, the slides were washed in 1x saline sodium citrate solution (SSC), 0.2% w/v SDS at 65 °C with constant agitation to remove the coverslips. The slides were then transferred to fresh 1xSSC, 0.2% w/v SDS solution and incubated at 65°C with constant mixing for 15 minutes. The slides were washed in 1xSSC for 2 x 5 minutes followed by 3 x 5 minute washes in 0.2xSSC. Finally, they were dried by centrifugation at 250 x g for 10 minutes at room temperature. The arrays were scanned using an Agilent G2565BA microarray scanner system (Agilent Technologies UK Limited, South Queensferry, UK). The array data and corresponding sample information (volunteer number, sex, BMI, age range and percentages of different leucocyte subsets) were made available in MIAME-compliant format by submission to the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) with array design accession number A-MEXP-170 and experiment accession number E-TABM-7.
Array image processing, data manipulation and normalisation
The array images were analysed with Agilent G2567AA Feature Extraction Software v7.1 (Agilent Technologies UK Limited, South Queensferry, UK) using the "wholespot" method with minimum feature signal background subtraction. Bad features, identified by visual inspection, were removed by manual flagging. The final data were exported into Excel and additional unreliable data points removed if they met any of the following criteria: saturation of any pixels within the feature in either channel, feature size less than 25 pixels, feature not found in either channel, or background corrected signal intensity less than 2.6xSD of background in both channels. Where the background corrected signal was greater than 2.6xSD of background signal in only one channel, a surrogate value (equal to the SD of the background) was used for the other channel.
The data were analysed using two approaches in different software packages. GeneSpring 7.2 (Agilent Technologies UK Limited, South Queensferry, UK) was employed to analyse the effects of discrete variables (i.e. sex and volunteer) and for subsequent hierarchical clustering. R (http://www.Rproject.org) was used to enable analysis of the effects of continuous variables (e.g. age, BMI, and percentages of different leucocyte subsets within samples). For the GeneSpring analysis, the edited raw data were imported and then normalised in a multi-stage process. First the Cy3 and Cy5 data for samples in batch 7 were reversed to account for inadvertent dye swap performed during sample preparation in this batch. Secondly, the data for each array underwent regional (by print pin) LoWess normalisation. Finally, to account for any batch-specific effects, the normalised Cy5/Cy3 ratio for each gene on each array was normalised against the mean ratio for that gene calculated from all arrays within the corresponding batch. Within R the raw data set was normalised initially using the same two first steps as for GeneSpring. The LoWess normalised data were finally subjected to Quantile normalisation using the Limma package (http://bioinf.wehi.edu.au/limma) to ensure consistent empirical distribution of intensities across arrays and across channels (17) .
Statistical analysis
The cross gene error model within GeneSpring was used to further filter the data to remove any features for which the signal intensity was too low to be considered reliable (12). The average value of base/proportional error for the entire set of arrays was calculated using this model (based on deviation from 1). Only genes for which the normalised control (Cy3) signal intensity was greater than this value in at least 95% of samples were used in subsequent analyses.
Within GeneSpring normalised data were analysed using Welch's t-test to investigate effects of gender on expression of individual genes. Welch's 1-Way analysis of variance was applied to investigate volunteer-specific effects.
In each case multiple test corrections (Benjamini and Hochberg false discovery rate or Holm) were applied. To provide a basis for examining intraindividual variation, coefficients of variations (CV) were calculated for each gene for each volunteer's set of five samples using the averaged normalised ratios of the technical replicates. The overall average of the CVs for each gene was calculated for the sample sets from all 18 volunteers. One-and twodimensional hierarchical clustering of selected gene lists was performed using standard correlations.
The same genes that passed the GeneSpring cross-gene error model filter, described above, were used for statistical analysis within R. The lmFit function from the Limma package was used to fit a linear model for each gene in the series of arrays with the log-ratio of gene expression as the dependent variable and independent variables sex, age, and BMI, as well as percentages of different leucocyte subsets in the samples, as determined by flow cytometry. When leucocyte subsets were included in the model, only the array data sets for which corresponding complete flow cytometric data had been obtained were included in the analysis (157 array data sets). Hybridization batch number was also incorporated into all the models to account for possible batch-specific effects. Moderated t-statistics and log-odds of differential expression were created by empirical Bayes shrinkage of the standard errors towards a common value, using the function eBayes (also from Limma).
RESULTS
Volunteer characteristics
The volunteers who completed the study ranged in age from 20 to 43 years (mean ± standard deviation = 34 ± 7) and in BMI from 17.1 to 30.8 (mean ± standard deviation = 23.7 ± 3.7). For the 10 female volunteers, the age range was 20 to 43 years (mean ± standard deviation = 34 ± 8) and the range of BMIs was 17.1 to 27.5 (mean ± standard deviation = 23.2 ± 3.9). For the 8 male volunteers, the age range was 24 to 42 (mean ± standard deviation = 34 ± 7) and the range of BMIs was 19.1 to 30.8 (mean ± standard deviation = 24.5 ± 3.6).
Data normalisation
A first round of data analysis within GeneSpring, in which the data were not normalised by batch, revealed significant batch-to-batch differences (data not shown). Batch-wise normalisation of the data was achieved by dividing the ratio for each gene by the mean of the ratios for that gene in that batch. No significant effects of batch were evident following this additional normalisation step (no significant differences using Welch's ANOVA with Benjamini and Hochberg multiple test correction with a false discovery rate of 5%).
Of the genes represented on the arrays, reliable signal (determined according to the criteria set out in the materials and methods section above) was obtained for 8,489 genes in at least 95% of samples. The expression profiles of these genes were examined for effects of sex, age, BMI, the presence of varying proportions of different leucocyte subsets and for patterns specific to individual volunteers.
Effects of different cell types
T-cells were most abundant leucocyte subset within the PBMC preparations accounting for 59.4 ± 7.5% of all the cells (mean ± standard deviation). It was assumed, therefore, that these cells would provide the predominant features of the PBMC sample transcriptional profiles with additional contributions from other cell subsets varying in a manner depending on their relative abundance in each sample. On this basis, the effects of the presence of varying amounts of other cell types present (i.e. B-cells, granulocytes, natural killer cells and monocytes) on the sample transcription profiles were analysed. B-cells and granulocytes were the least abundant cells in the PBMC preparations at 5.3 ± 2.0% and 0.1 ± 0.2% of the total cell count, respectively. Natural killer cells and monocytes were present as 12.3 ± 6.3% and 21.2 ± 6.3%, respectively, of the total cells within the PBMC samples. There were no detectable effects on the expression of any genes due to variations in the percentages of B-cells or granulocytes. The expression of 28 genes correlated significantly with the abundance of natural killer cells (Table 4 ). Amongst these were four killer cell immunoglobulin-like receptor genes (KIR2DL2, KIR2DL3, KIR3DL2 and KIR3DS3) and two killer cell lectin-like receptors (KLRF1 and KLRC2) all of which correlated positively with the percentage of natural killer cells. The expression of 67 genes correlated significantly with the percentage of monocytes present (the 50 genes with the lowest p values are shown in Table  5 ). These included genes involved in diverse cellular functions such as immune, inflammatory and defence responses, transcriptional regulation, cell proliferation and development.
Comparison between genders
Analysis performed within R using a linear model incorporating sex, age and BMI suggested that expression of 51 genes differed significantly between the sexes (i.e. corrected p-values less than 0.05). When leucocyte subpopulations were also incorporated into the model, the number of genes identified as exhibiting sex-specific differences decreased to 28 (Table 1) . Of these 28 genes, 14 were present on either the X or Y chromosomes (XIST, DDX3Y and DDX3X, CYorf15B and CXorf15, UTY, JARID1D, RPS4Y1, SMC1L1, UBE1, EIF1AX, ZFX, USP9X, and CD99).
When a comparison was performed using 1-way analysis of variance in GeneSpring, fifty-five genes were identified that apparently exhibited significant sex-specific differences in expression levels (as determined using Welch's t-test with Holm multiple test correction and a family-wise error rate of 0.05). This gene list overlapped substantially with the lists obtained using linear model in R: 38 of the 51 and 24 of the 28 genes identified with the different linear models in R were identical to genes identified using GeneSpring. The genes common to all lists corresponded predominantly to those identified with the lowest p-values in the different analytical procedures while the discrepancies were in genes with p-values close to the cut-off.
Effects of age
When a linear regression model incorporating sex, age and BMI as independent variables was employed, 31 genes were identified that exhibited apparent age-dependent expression. When the full model including leucocyte cell subsets was used, the number decreased to 24 ( Table 2) . Predominant among these age-dependent genes were immunoglobulins (12 of 24); transcript levels of all of which decreased significantly with age. These included different rearrangements of the variable regions for both heavy and light chains plus the immunoglobulin J chain. There was no significant correlation between B-cell number in the PBMC preparations and age.
Effects of BMI
The linear regression model incorporating sex, age and BMI as independent variables identified 64 genes that exhibited apparent BMI-dependent expression. However, it was notable that inclusion of leucocyte cell subsets in the model caused this number to drop to only 3 (Table 3 ). This decrease was found to result primarily from a strong correlation between BMI and percentage of monocytes, and to a lesser extent natural killer cells, in the PBMC preparations (R 2 = 0.6 for the best fit linear regression model analysis incorporating both monocytes and natural killer cells as explanatory variables; R 2 = 0.44 for the best fit model when only monocytes were considered). The three genes that remained as significantly affected by BMI were CD151 (GP27/SFA1/PETA-3) and TGFBI, both of which showed inverse correlations, and IFI44L (C1orf29), which increased with BMI.
Intra-and Inter-individual variation
Overall, the within-subject variation in expression of most individual genes was found to be comparatively low. The average within-subject CV was less than 20% for 6777 [80%] of the 8,489 genes examined. Hierarchical clustering of the genes with the highest average within-subject CVs (134 genes with CVs of 40-63%) revealed the presence of large cluster of 25 immunoglobulin genes (Figure 1 ).
An overview of all genes for which mRNA levels differed significantly between sample sets from different donors was obtained by using Welch 1-way ANOVA with Benjamini and Hochberg multiple test correction with a false discovery rate of 5%. A high proportion of the genes analysed in this way exhibited apparent volunteer-specific differences in expression (3302 of 8489 [39%]. Two-dimensional hierarchical clustering was performed with smaller subsets genes for which transcript levels were identified as varying between individuals. As might be expected using this approach, lists of 431 down to as few as 137 genes (obtained using Welch's 1-way ANOVA and Holm multiple test correction with family-wise error rates of 10 -3 down to 10 -7 ), gave rise to perfect clustering of the sample sets both by sex and by volunteer ( Figure 2) . A number of gene clusters were identified in which all or most of the genes were found to have related functions or regulation. These included a cluster of 12 immunoglobulin genes and a cluster of nine genes, seven of which are known to be regulated, by interferons (FER1L3, Ly6E, G1P2/IFI15/ISG15, OAS3, IFI44, IFI44L and STAT1), one belongs to a family of enzymes for which there is evidence of regulation by interferons (LAP3) and one of unknown function. There were also X-and Y-linked gene clusters, and a cluster of four killer cell lectin genes (KLRC1, KLRC2, KLRC4 and KLRK1). Another cluster of 81 genes was identified that was noted to contain a high proportion (11) of histone genes. In addition to these, the full list of 431 genes obtained with a family-wise error rate of 10 -3 was found to contain genes involved in a very wide range of biological functions.
DISCUSSION
The design of the study described here was intended to minimise differences in gene expression due to factors that can be controlled for routinely in clinical studies, such as normal variation in sample cell type sub-populations, sample processing artefacts, diurnal variation and the acute effects of food intake. Conversely, the study maximised the potential effects of certain biological factors that may be more difficult to account for, such as day-specific effects and hormonal effects due to the menstrual cycle for female volunteers. In this respect, the study could be considered to provide a "worst case scenario" for design of future studies in respect of both inter-and intra-individual variation due to biological effects that may be difficult to avoid.
To our knowledge, only two studies have been published that relate directly to the one described here (10, 16). Radich and co-workers used a similar study design but focussed on gene transcript profiles in mixed leucocyte populations from whole blood samples (10). Whitney and co-workers performed a study that included analysis of expression profiles both in mixed leucocytes from whole blood and PBMC from healthy volunteers (16) .
Overall, there were some notable common features in the results obtained from the current study and those described by Whitney and co-workers and Radich and co-workers. For example, a number of major histocompatibility class II genes were identified as varying between donors in all three studies (HLA-DQ [ and ] chains in all three studies and HLA-RD in the current study and the study of Whitney et al.) . Also notable was the common theme of inter-individual variation in specific interferon-regulated genes. Whitney and co-workers identified a cluster of six interferon-regulated genes (OAS3, MTAP44, INADL, MX1, IFIT44L/GS3686 and IFIT1) that varied between individuals. Radich and co-workers identified a cluster of five such genes, which overlapped partially with those described by Whitney and co-workers (CIG5, IFIT1, IFIT4, MX1 and USP18).
In the study described here, when two-dimensional hierarchical clustering was performed with 431 genes identified as varying between individuals using Holm multiple test correction with a cut-off value of 10 -3 , a cluster of nine genes was identified of which seven were genes known to be interferonregulated (FER1L3, Ly6E, G1P2/IFI15/ISG15, OAS3, IFI44, IFI44L/GS3686 and STAT1) and one gene belonged to a family for which there is evidence of interferon-regulation (LAP3) (8, 13) . The remaining gene represents a novel candidate for interferon-regulation (SMAP52). In addition, MX1 was identified as varying between individuals in the current study when the less stringent Benjamini and Hochberg multiple test correction with a false discovery rate of 5% was applied. Finally, in both in the current study and that described by Whitney and co-workers, immnunoglobulin genes (including different forms of light and heavy chains and the J-chain) were identified as being highly represented in the lists of genes that decreased in expression in an agedependent manner. This appears to be in accordance with the finding that serum IgG and IgM levels reduce with increasing age (3).
However, the full extent of overlap between the genes of interest identified in the three studies as varying significantly with the parameters investigated was rather limited. For example, of the 72 genes identified by Radich and coworkers as varying between individual in mixed leucocyte populations from whole blood, only 22 were present in the list of 3,302 genes identified in the current study as varying significantly between volunteers. Of the 20 genes that were found to be most significantly differentially expressed between volunteers in the current study, three genes were also identified as varying in expression with sex in both the current study and the study of Whitney and co-workers (XIST, CYorf15B and UTY), one gene was common to the list of genes identified as varying between individuals in the study of Radich and coworkers (GNG11), and only one gene was found to vary between individuals in all three studies (HLA-RD chain). The majority of the 3,302 genes that were identified as varying significantly in transcript levels between volunteers represent findings unique to this study.
Differences between the genes identified and the interpretation of results in the various studies discussed here are likely to have resulted from technical differences in the array platforms used, the genes represented on the arrays and the analytical procedures used. Variation in the leucocyte subsets analysed (e.g. leucocytes from whole blood versus PMBC used) will also have had a bearing on the results, which makes direct comparison more difficult. In the present study, a comparatively small number of genes were identified for which the transcript levels correlated with differences in leucocyte subsets in the PBMC samples analysed. This suggests that use of PBMC rather than whole blood is an effective approach for reducing inter-sample variation.
From their analyses, Whitney and co-workers concluded that there were intrinsic individual differences in the expression of a number of genes in PBMC, but that these were not the dominant source of variation in gene expression among the samples. The conclusions of the current study tend to suggest the reverse. Within-individual variation in the expression of most genes was low. However, a large proportion of the genes analysed (up to 39%) exhibited statistically significant differences between individuals. This difference in interpretation is most likely due to factors of study design and statistical analysis. For the study described here, the number of sample analysed and, in particular, the greater and consistent number of samples obtained from each volunteer will have increased the statistical power, and will have enhanced detection in inter-individual differences in gene expression compared with the equivalent component of the study of Whitney and coworkers. Also, the samples for the current study were collected according to a more closely controlled regimen: at weekly intervals and always first thing in the morning after an overnight fast. The samples for Whitney's study were collected at variable intervals, the volunteers were not specifically fasted and the samples were taken at different times of day. This reflects differences in the aims of the two studies rather than any study design fault. However, such factors may well have served to increase the within-individual variation observed. Indeed Whitney and co-workers were able to identify a number of genes whose expression varied according to the time the samples were collected (16) . It was not possible to evaluate acute effects of food intake in either study.
We used two parallel approaches and software systems to analyse the data. This enabled analyses of both discrete and continuous variables. As microarray data interrogation is still a developing field there were, inevitably, slight differences in the data normalisation processes used for the different approaches and the statistical approaches were quite distinct. However, for sex (the only parameter investigated using both approaches) it was reassuring to note the substantial overlap in genes identified by the two methods as exhibiting sex-specific differences in transcript levels. The genes that were identified using both approaches were generally those for which the calculated p-values were lowest. This suggests that both approaches were valid.
Sample processing prior to RNA isolation introduces potential for generation of artefacts resulting from alterations in the expression of certain genes during processing. Indeed, it has been suggested that the typical gene transcription profile of RNA prepared from isolated PBMC may carry a "fingerprint" that is symptomatic of a stress response (16) . Additionally, changes in gene expression have been reported as a result of varying delays between collection of blood samples and subsequent RNA isolation (10). In the current study, all possible practical measures were taken to ensure that the PBMC were always isolated as quickly as possible after obtaining blood samples. Just as importantly, the isolation protocol was set up with a view to maximising the consistency of the process and minimising operator differences. Thus, while it is possible that changes in gene expression did arise during sample processing, the objective to keep this to a minimum and as consistent as possible between samples was achieved.
It is not possible to be certain which of the factors discussed above are primarily responsible for the differences in gene transcription profiles reported between the various studies. However, these differences do not mean that any of the results are necessarily invalid. Indeed, these types of apparent discrepancy are common in all biological research. The particular issue with microarray studies is that the volume of data generated is so much larger than in was previously achievable that discrepancies may promote confusion rather than clarification. Clearly, the findings that are most consistent between the studies serve as an obvious point for initial follow up but the other data should not be ignored. Rather these studies serve to highlight the fact that improved standardisation in the design, execution and analysis of array studies, to accompany the established standards of array data reporting, would facilitate cross-study comparisons.
The genes that were found to vary most within individuals represent an intriguing group. The possibility that some, perhaps all, of the enhanced between-sample variation observed for these genes may have arisen from technical errors due to array design factors cannot be ruled out. However, the presence of a large number of immunoglobulin genes within this group that co-segregated when analysed by hierarchical clustering lends credence to the idea that this process did not select random genes that varied due solely to technical factors. Rather it seems more likely that many of these genes do indeed vary significantly in expression at the level of transcription from day-today. If so, these correspond to genes that would appear to be exquisitely sensitive to environmental factors.
As discussed above clusters of immunoglobulin genes were also identified as varying in mRNA transcript levels significantly with donor age and between volunteers. This suggests that both genetic and environmental factors are important in the regulation of their expression, consistent with what we already known about immunoglobulin function, regulation of gene expression and inter-individual variations in response to immune challenges.
In conclusion, this study extends the limited information base currently available that describes normal patterns of gene expression and variation at the level of mRNA in human tissues. The data generated has been made freely available and should represent a useful resource for the design of future studies. A host of new candidate genes for regulation by genetic, life-stage and environmental factors were identified. These could be used as a basis for hypothesis development. Substantial differences in gene expression profiles were identified between individuals. Conversely, PBMC gene transcription profiles were found to be remarkably consistent within serial samples obtained from individuals. This suggests that the scope for future clinical and nutritional intervention studies using gene expression profiling is considerable, provided care is taken in the study design to account for inter-individual differences and in sample preparation to avoid, or at least minimise, introduction of processing artefacts. The baseline data generated should find use in the execution of power calculations for the design of such studies. 
